Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.1%

1 terminated out of 48 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results91% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (17)
Early P 1 (1)
P 1 (7)
P 2 (6)
P 3 (2)

Trial Status

Not Yet Recruiting19
Recruiting11
Completed10
Enrolling By Invitation3
Active Not Recruiting2
Suspended1

Trial Success Rate

90.9%

Benchmark: 86.6%

Based on 10 completed trials

Clinical Trials (48)

Showing 20 of 20 trials
NCT07659964Not ApplicableRecruitingPrimary

Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

NCT07741071Phase 2Not Yet RecruitingPrimary

N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease

NCT07600996Recruiting

Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease

NCT07639645Not ApplicableNot Yet RecruitingPrimary

Intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer

NCT07646054Not ApplicableNot Yet Recruiting

Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers

NCT07611357Phase 2Not Yet RecruitingPrimary

[18F]F-AraG PET Imaging in Alzheimer's Disease

NCT07598617RecruitingPrimary

The Co-Production and Evaluation of the Computerised Cognitive Assessment for Preclinical Alzheimer's Disease (CoCoA-PAD)

NCT07554872Phase 1Not Yet RecruitingPrimary

Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease

NCT07564700Not ApplicableNot Yet RecruitingPrimary

A Study Testing Whether Low-Dose Radiation Could Help the Immune System and Possibly Improve Early-Onset Alzheimer's Disease.

NCT07558785Not ApplicableEnrolling By Invitation

Telemedicine Self-examination of Speech and Memory for Rapid Detection of Cognitive Impairments Using Machine Learning Methods

NCT07526480Not ApplicableNot Yet RecruitingPrimary

Improving Dementia Care in Primary Practice

NCT07505095Not Yet RecruitingPrimary

Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

NCT07127510RecruitingPrimary

Brain NAD in Alzheimer's Disease

NCT07180147Active Not RecruitingPrimary

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

NCT07431255Not Yet RecruitingPrimary

Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease

NCT06831812Phase 1Completed

Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine

NCT07422038Not Yet RecruitingPrimary

BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) - Improving Access to Alzheimer's Disease Diagnostics: A Pragmatic System Level Intervention

NCT07385937Not ApplicableNot Yet RecruitingPrimary

Effectiveness of Genistein in Mild Cognitive Impairment

NCT03402919Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

NCT07234695Phase 3Recruiting

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

Scroll to load more

Research Network

Activity Timeline